{"transactions":[{"id":3168364,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2020-04-28T17:43:42.000Z","date":"2020-04-26","kind":"exercise","acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted 5,000 Restricted Stock Units (\"RSUs\") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted 5,000 Restricted Stock Units (\"RSUs\") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter."}],"balance_after":2917,"derivative":{"underlying":"Ordinary Shares","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001209191-20-025893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120025893/doc4.xml","form_type":"4"}},{"id":3168363,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-28T17:43:42.000Z","date":"2020-04-27","kind":"sale","acquired":false,"shares":145,"price":24.35,"value":3530.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":10084,"source":{"system":"sec-edgar","filing":"0001209191-20-025893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120025893/doc4.xml","form_type":"4"}},{"id":3168362,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-28T17:43:42.000Z","date":"2020-04-26","kind":"exercise","acquired":true,"shares":417,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":10229,"source":{"system":"sec-edgar","filing":"0001209191-20-025893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120025893/doc4.xml","form_type":"4"}},{"id":3266956,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-18T19:33:38.000Z","date":"2020-02-14","kind":"exercise","acquired":false,"shares":1759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate.  1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate.  1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years."}],"balance_after":7037,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1759},"source":{"system":"sec-edgar","filing":"0001209191-20-009943","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120009943/doc4.xml","form_type":"4"}},{"id":3266955,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-18T19:33:38.000Z","date":"2020-02-14","kind":"sale","acquired":false,"shares":612,"price":28.04,"value":17160.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":9812,"source":{"system":"sec-edgar","filing":"0001209191-20-009943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120009943/doc4.xml","form_type":"4"}},{"id":3266954,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-18T19:33:38.000Z","date":"2020-02-14","kind":"exercise","acquired":true,"shares":1759,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":10424,"source":{"system":"sec-edgar","filing":"0001209191-20-009943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120009943/doc4.xml","form_type":"4"}},{"id":3291815,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted stock unit","published_at":"2020-02-04T17:39:06.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."}],"balance_after":3000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-20-006211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120006211/doc4.xml","form_type":"4"}},{"id":3291814,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock options (right to buy)","published_at":"2020-02-04T17:39:06.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."}],"balance_after":15000,"derivative":{"exercise_price":29.41,"underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-006211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120006211/doc4.xml","form_type":"4"}},{"id":3300143,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2020-01-28T22:14:08.000Z","date":"2020-01-26","kind":"exercise","acquired":false,"shares":1666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted 5,000 Restricted Stock Units (\"RSUs\") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted 5,000 Restricted Stock Units (\"RSUs\") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter."}],"balance_after":3334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1666},"source":{"system":"sec-edgar","filing":"0001209191-20-005211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120005211/doc4.xml","form_type":"4"}},{"id":3300142,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-28T22:14:08.000Z","date":"2020-01-27","kind":"sale","acquired":false,"shares":684,"price":29.26,"value":20013.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":8665,"source":{"system":"sec-edgar","filing":"0001209191-20-005211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120005211/doc4.xml","form_type":"4"}},{"id":3300141,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-28T22:14:08.000Z","date":"2020-01-26","kind":"exercise","acquired":true,"shares":1666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":9349,"source":{"system":"sec-edgar","filing":"0001209191-20-005211","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120005211/doc4.xml","form_type":"4"}},{"id":3368346,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-11-18T21:04:31.000Z","date":"2019-11-14","kind":"exercise","acquired":false,"shares":1759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate.  1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate.  1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years."}],"balance_after":8796,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1759},"source":{"system":"sec-edgar","filing":"0001209191-19-056923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119056923/doc4.xml","form_type":"4"}},{"id":3368345,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-18T21:04:31.000Z","date":"2019-11-14","kind":"sale","acquired":false,"shares":608,"price":25.9973,"value":15806.3584,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":7683,"source":{"system":"sec-edgar","filing":"0001209191-19-056923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119056923/doc4.xml","form_type":"4"}},{"id":3368344,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-18T21:04:31.000Z","date":"2019-11-14","kind":"exercise","acquired":true,"shares":1759,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":8291,"source":{"system":"sec-edgar","filing":"0001209191-19-056923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119056923/doc4.xml","form_type":"4"}},{"id":3436245,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-08-16T19:38:37.000Z","date":"2019-08-14","kind":"exercise","acquired":false,"shares":1759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate.  1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate.  1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years."}],"balance_after":10555,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1759},"source":{"system":"sec-edgar","filing":"0001209191-19-046282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119046282/doc4.xml","form_type":"4"}},{"id":3436244,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-16T19:38:37.000Z","date":"2019-08-15","kind":"sale","acquired":false,"shares":608,"price":31.65,"value":19243.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":6532,"source":{"system":"sec-edgar","filing":"0001209191-19-046282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119046282/doc4.xml","form_type":"4"}},{"id":3436243,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-16T19:38:37.000Z","date":"2019-08-14","kind":"exercise","acquired":true,"shares":1759,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":7140,"source":{"system":"sec-edgar","filing":"0001209191-19-046282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119046282/doc4.xml","form_type":"4"}},{"id":3523901,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-05-16T22:20:01.000Z","date":"2019-05-14","kind":"exercise","acquired":false,"shares":1759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years."}],"balance_after":12314,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1759},"source":{"system":"sec-edgar","filing":"0001209191-19-030594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119030594/doc4.xml","form_type":"4"}},{"id":3523900,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-16T22:20:01.000Z","date":"2019-05-14","kind":"sale","acquired":false,"shares":608,"price":37.98,"value":23091.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":5381,"source":{"system":"sec-edgar","filing":"0001209191-19-030594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119030594/doc4.xml","form_type":"4"}},{"id":3523899,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-16T22:20:01.000Z","date":"2019-05-14","kind":"exercise","acquired":true,"shares":1759,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":5989,"source":{"system":"sec-edgar","filing":"0001209191-19-030594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119030594/doc4.xml","form_type":"4"}},{"id":3606317,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-08T02:44:28.000Z","date":"2019-02-14","kind":"exercise","acquired":false,"shares":7034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019 (with the issuance of the underlying ordinary shares delayed until March 5, 2019), with the balance vesting in equal quarterly installments thereafter over a period of two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted restricted stock units (\"RSUs\") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019 (with the issuance of the underlying ordinary shares delayed until March 5, 2019), with the balance vesting in equal quarterly installments thereafter over a period of two years."}],"balance_after":14073,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7034},"source":{"system":"sec-edgar","filing":"0001209191-19-017932","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119017932/doc4.xml","form_type":"4"}},{"id":3606316,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-08T02:44:28.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":2804,"price":37.3,"value":104589.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":4230,"source":{"system":"sec-edgar","filing":"0001209191-19-017932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119017932/doc4.xml","form_type":"4"}},{"id":3606315,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-08T02:44:28.000Z","date":"2019-02-14","kind":"exercise","acquired":true,"shares":7034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":7034,"source":{"system":"sec-edgar","filing":"0001209191-19-017932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119017932/doc4.xml","form_type":"4"}},{"id":3683872,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-01-29T22:26:32.000Z","date":"2019-01-26","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.33% of the RSUs will vest on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"33.33% of the RSUs will vest on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter."}],"balance_after":5000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-005805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119005805/doc4.xml","form_type":"4"}},{"id":3683871,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":149635,"kind":"person","name":"Mullennix Stephen","position":1,"cik":"0001764139","reported_name":"Mullennix Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-29T22:26:32.000Z","date":"2019-01-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33.33% of the shares underlying the stock option will vest on January 26, 2020 and 12.5% of the remaining shares will vest in eight equal quarterly installments thereafter."}],"balance_after":15000,"derivative":{"exercise_price":42.5,"expiration_date":"2029-01-26","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-005805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919119005805/doc4.xml","form_type":"4"}}]}